Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists.
about
Advances and challenges in the search for D2 and D3 dopamine receptor-selective compounds.Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs.In silico studies targeting G-protein coupled receptors for drug research against Parkinson's disease.Structure-Activity Investigation of a G Protein-Biased Agonist Reveals Molecular Determinants for Biased Signaling of the D2 Dopamine Receptor.A single amino acid substitution in CXCL12 confers functional selectivity at the beta-arrestin level.
P2860
Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists.
@en
Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists.
@nl
type
label
Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists.
@en
Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists.
@nl
prefLabel
Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists.
@en
Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists.
@nl
P2093
P2860
P1476
Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists.
@en
P2093
Bryan L Roth
John D McCorvy
Kyle V Butler
Matthew G Fischer
Yudao Shen
P2860
P304
10601-10618
P356
10.1021/ACS.JMEDCHEM.6B01208
P407
P577
2016-11-02T00:00:00Z